227 related articles for article (PubMed ID: 28453918)
1. Value of brush cytology for optimal timing of liver transplantation in primary sclerosing cholangitis.
Vannas MJ; Boyd S; Färkkilä MA; Arola J; Isoniemi H
Liver Int; 2017 May; 37(5):735-742. PubMed ID: 28453918
[TBL] [Abstract][Full Text] [Related]
2. Suspicious brush cytology is an indication for liver transplantation evaluation in primary sclerosing cholangitis.
Boyd S; Vannas M; Jokelainen K; Isoniemi H; Mäkisalo H; Färkkilä MA; Arola J
World J Gastroenterol; 2017 Sep; 23(33):6147-6154. PubMed ID: 28970730
[TBL] [Abstract][Full Text] [Related]
3. Role of biliary brush cytology in primary sclerosing cholangitis.
Lal A; Okonkwo A; Schindler S; De Frias D; Nayar R
Acta Cytol; 2004; 48(1):9-12. PubMed ID: 14969174
[TBL] [Abstract][Full Text] [Related]
4. Surveillance of primary sclerosing cholangitis with ERC and brush cytology: risk factors for cholangiocarcinoma.
Boyd S; Mustonen H; Tenca A; Jokelainen K; Arola J; Färkkilä MA
Scand J Gastroenterol; 2017 Feb; 52(2):242-249. PubMed ID: 27806633
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic performance of a stepwise cytological algorithm for biliary malignancy in primary sclerosing cholangitis.
von Seth E; Ouchterlony H; Dobra K; Hjerpe A; Arnelo U; Haas S; Bergquist A
Liver Int; 2019 Feb; 39(2):382-388. PubMed ID: 30507030
[TBL] [Abstract][Full Text] [Related]
7. Screening primary sclerosing cholangitis and biliary dysplasia with endoscopic retrograde cholangiography and brush cytology: risk factors for biliary neoplasia.
Boyd S; Tenca A; Jokelainen K; Mustonen H; Krogerus L; Arola J; Färkkilä MA
Endoscopy; 2016 May; 48(5):432-9. PubMed ID: 26808393
[TBL] [Abstract][Full Text] [Related]
8. Optimizing the detection of biliary dysplasia in primary sclerosing cholangitis before liver transplantation.
Majeed A; Castedal M; Arnelo U; Söderdahl G; Bergquist A; Said K
Scand J Gastroenterol; 2018 Jan; 53(1):56-63. PubMed ID: 28990806
[TBL] [Abstract][Full Text] [Related]
9. [Cytology is in pivotal role at screening and surveillance of PSC].
Boyd S; Arola J; Mäkisalo H; Färkkilä M
Duodecim; 2014; 130(22-23):2397-404. PubMed ID: 25558600
[TBL] [Abstract][Full Text] [Related]
10. Monitoring dominant strictures in primary sclerosing cholangitis with brush cytology and FDG-PET.
Sangfelt P; Sundin A; Wanders A; Rasmussen I; Karlson BM; Bergquist A; Rorsman F
J Hepatol; 2014 Dec; 61(6):1352-7. PubMed ID: 25111173
[TBL] [Abstract][Full Text] [Related]
11. Value of brush cytology for dominant strictures in primary sclerosing cholangitis.
Ponsioen CY; Vrouenraets SM; van Milligen de Wit AW; Sturm P; Tascilar M; Offerhaus GJ; Prins M; Huibregtse K; Tytgat GN
Endoscopy; 1999 May; 31(4):305-9. PubMed ID: 10376457
[TBL] [Abstract][Full Text] [Related]
12. Biliary dysplasia in patients with primary sclerosing cholangitis: additional value of DNA ploidity.
Halme L; Arola J; Numminen K; Krogerus L; Mäkisalo H; Färkkilä M
Liver Int; 2012 May; 32(5):783-9. PubMed ID: 22098817
[TBL] [Abstract][Full Text] [Related]
13. Cholangiocarcinoma in situ in primary sclerosing cholangitis: diagnosis by brush cytology and treatment by liver transplantation.
Boberg KM; Jebsen P; Clausen OP; Aabakken L; Brekke I; Schrumpf E
J Hepatol; 2003 Sep; 39(3):453. PubMed ID: 12927935
[No Abstract] [Full Text] [Related]
14. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
15. Effect of single operator cholangioscopy on accuracy of bile duct cytology.
Aly FZ; Mostofizadeh S; Jawaid S; Knapik J; Mukhtar F; Klein R
Diagn Cytopathol; 2020 Dec; 48(12):1230-1236. PubMed ID: 32770823
[TBL] [Abstract][Full Text] [Related]
16. An Optimized Set of Fluorescence In Situ Hybridization Probes for Detection of Pancreatobiliary Tract Cancer in Cytology Brush Samples.
Barr Fritcher EG; Voss JS; Brankley SM; Campion MB; Jenkins SM; Keeney ME; Henry MR; Kerr SM; Chaiteerakij R; Pestova EV; Clayton AC; Zhang J; Roberts LR; Gores GJ; Halling KC; Kipp BR
Gastroenterology; 2015 Dec; 149(7):1813-1824.e1. PubMed ID: 26327129
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer.
Linder S; Söderlund C
Hepatogastroenterology; 2001; 48(38):387-92. PubMed ID: 11379315
[TBL] [Abstract][Full Text] [Related]
18. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
[TBL] [Abstract][Full Text] [Related]
19. Predicting cholangiocarcinoma in patients with primary sclerosing cholangitis before transplantation.
Miros M; Kerlin P; Walker N; Harper J; Lynch S; Strong R
Gut; 1991 Nov; 32(11):1369-73. PubMed ID: 1661259
[TBL] [Abstract][Full Text] [Related]
20. CA19-9 does not predict cholangiocarcinoma in patients with primary sclerosing cholangitis undergoing liver transplantation.
Fisher A; Theise ND; Min A; Mor E; Emre S; Pearl A; Schwartz ME; Miller CM; Sheiner PA
Liver Transpl Surg; 1995 Mar; 1(2):94-8. PubMed ID: 9346547
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
